CSIMarket Company Name, Ticker, Competitors, else..
 
Theravance Biopharma inc   (NASDAQ: TBPH)
 
Price: $17.0250 $0.01 0.088%
Day's High: $17.045000076293945 Week Perf: -0.21 %
Day's Low: $ 17.01 30 Day Perf: 0.62 %
Volume (M): 130,883 52 Wk High: $ 21.03
Volume (M$): $ 0 52 Wk Avg: $16.81
Open: $17.01 52 Wk Low: $13.08



 Market Capitalization (Millions $) 880
 Shares Outstanding (Millions) 52
 Employees 90
 Revenues (TTM) (Millions $) 104
 Net Income (TTM) (Millions $) 54
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) 0

Business Description


Theravance Biopharma Inc. is a pharmaceutical company that specializes in the discovery, development, and commercialization of small molecule medicines. They focus on various therapeutic areas including respiratory diseases, gastrointestinal disorders, and infectious diseases. Their objective is to create innovative treatments that improve patient care and offer significant advancements in the field of biopharmaceutical research. The company utilizes a proprietary technology platform to identify new drug candidates and aims to deliver breakthrough therapies that address unmet medical needs.


   Company Address: C/O Theravance Biopharma US, LLC South San Francisco 94080 CA
   Company Phone Number: 808-6000   Stock Exchange / Ticker: NASDAQ TBPH


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BMY   -4.2%    
JNJ   -2.74%    
LLY   -0.65%    
MRK   -3.31%    
PFE   -2.48%    
TEVA        6.46% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 16.37
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 8.43
Price to Sales (Expected) -
Price to Book 3.04
PEG (TTM) 0.05

Financial Strength Current
Quick Ratio 12.3
Working Capital Ratio 12.66
Leverage Ratio (MRQ) 0.62
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 1.04 $
Revenues (TTM) 2.02 $
Cash Flow (TTM) 0.12 $
Cash 7.33 $
Book Value 5.61 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 1,159,011
Net Income per Employee (TTM) 597,867
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.23

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -39.93 %
Net Margin (MRQ) -28.45 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 8.67 %

Management Effectiveness Current
Return On Assets (TTM) 11.61 %
Return On Investment (TTM) 17.1 %
Return On Equity (TTM) 19.4 %
Dividend Yield -
Pay out Ratio (TTM) -



Theravance Biopharma Inc's Segments
Collaborative Arrangement Revenue    185.37 % of total Revenue
Yupelri Monotherapy    224.71 % of total Revenue
Single reportable segment    185.37 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.